About this trial
First, to date, no data are available on the thyroid volume of full-term newborns in Italy, making it essential to conduct studies to establish reference values for normality. This allows these values to be correlated with maternal and fetal variability, providing a scientific basis for better understanding thyroid development in the first days of life. Thyroid ultrasound is useful for supplementing newborn screening for congenital hypothyroidism, helping to identify early abnormalities. Furthermore, thyroid volume is a sensitive indicator of iodine intake, essential for assessing the population's iodine nutritional status. It is equally valuable for studying and monitoring the effects of maternal and environmental factors, for which thyroid volume itself serves as a marker. Having normal values allows for a more precise comparison and contextualization of data from children with pathologies, who undergo ultrasound for pathological screening. In summary, these regulatory references improve the diagnosis, prevention, and management of neonatal thyroid dysfunction, contributing to a more informed public health.
Eligibility criteria
Qualifiers
Healthy full term newborns (born between 37 and 42 weeks of gestation, with no antennal issue or complications at birth)
Consent obtained by parent(s) or legal guardian(s)
Disqualifiers
Congenital malformations
TSH abnormalities in neonatal screening
Pregnancy not carried out in Italy, due to different iodine status
Inability or unwillingness of the parent(s) or legal guardian(s) to provide informed consent or to comply with study procedures
Trial design
Treatments tested in this trial
- Thyroid ultrasound